Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer.
El-Tanani M, Platt-Higgins A, Nsairat H, Matalka II, Ahmed KA, Zhang SD, Alshaer W, Awidi A, Matchett KB, Aljabali AA, Mishra V, Serrano-Aroca Á, Tambuwala MM, Rudland PS.
El-Tanani M, et al. Among authors: matalka ii.
Life Sci. 2023 Sep 15;329:121964. doi: 10.1016/j.lfs.2023.121964. Epub 2023 Jul 18.
Life Sci. 2023.
PMID: 37473800